Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$7.63
+7.55%
Mkt Cap $478.75M
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
Implied Upside
+93.4%
Consensus $14.75 vs current $7.63
NASDAQ·Healthcare·Biotechnology
$7.63
+7.55%
Mkt Cap $478.75M
Buy
11
Hold
1
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
+93.4%
Consensus $14.75 vs current $7.63